Cambridge, MA, United States of America

Patrick Ryan McCarren


 

Average Co-Inventor Count = 20.7

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Innovative Contributions of Patrick Ryan McCarren in Pharmaceutical Science

Introduction

Patrick Ryan McCarren, a prominent inventor based in Cambridge, MA, has made significant strides in the field of pharmaceutical sciences. With an impressive portfolio of 9 patents, he has dedicated his career to developing innovative compounds that hold potential for treating various diseases, particularly hyperproliferative disorders.

Latest Patents

Among his latest inventions are two notable patents focused on macrocyclic indole derivatives. The first, titled "Macrocyclic fluorine substituted indole derivatives," pertains to a specific class of macrocyclic indole compounds characterized by a general formula (I). This invention details methods for synthesizing these compounds, related intermediate compounds, and their application in pharmaceutical compositions. The compounds are intended for use in the treatment or prevention of hyperproliferative disorders, both as standalone therapies and in combination with other active ingredients.

The second patent, "Substituted macrocyclic indole derivatives," similarly explores substituted macrocyclic indole derivatives, following a comparable structure and purpose. Both patents highlight McCarren's innovative approach to drug development, aiming to enhance therapeutic outcomes for patients suffering from serious health conditions.

Career Highlights

Throughout his career, McCarren has been associated with esteemed organizations such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His work within these companies has had a significant impact on the advancement of pharmaceutical research and development. His time at Bayer reflects his commitment to excellence in innovation and the creation of effective therapeutic agents.

Collaborations

Collaboration has been a key aspect of McCarren's success in the industry. He has worked alongside notable coworkers, including Sarah Anna Liesa Johannes and Clara Christ, who have contributed to his projects and innovations. These partnerships showcase the collaborative nature of research and development in the pharmaceutical field.

Conclusion

Patrick Ryan McCarren's dedication to innovation in pharmaceutical science is reflected in his numerous patents and collaborative efforts. His pioneering work on macrocyclic indole derivatives positions him as a significant figure in the pursuit of novel therapeutic solutions. As he continues to advance his research, the implications of his inventions may play a crucial role in the treatment of hyperproliferative disorders, offering hope to many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…